Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets - (Unaudited)

v3.21.2
Consolidated Balance Sheets - (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 147,287 $ 105,778
Cash held in escrow 10,761 11,618
Restricted cash 0 4,270
Real estate inventories (including related party interest of $11,479 and $18,721, respectively) 877,883 687,819
Due from affiliates 3,584 2,663
Investment in and advances to unconsolidated joint ventures (including related party interest of $556 and $1,320, respectively) 11,604 21,342
Goodwill 24,607 20,705
Other assets 33,093 41,569
Total assets 1,108,819 895,764
Liabilities    
Accounts payable 54,912 36,243
Accrued expenses and other liabilities 70,786 62,869
Due to affiliates 2,176 2,357
Warrant liability 21,560 0
Notes and other debts payable, net  391,844 264,809
Total liabilities 541,278 366,278
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 46,281,091 and 32,557,303 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 5  
Additional paid-in capital 530,660 496,171
Retained earnings 35,601 32,011
Total stockholders' equity 566,266 528,185
Noncontrolling interests 1,275 1,301
Total equity 567,541 529,486
Total liabilities and equity $ 1,108,819 895,764
Cumulative Effect, Period of Adoption, Adjusted Balance    
Stockholders' equity:    
Common stock, $0.0001 par value, 500,000,000 shares authorized, 46,281,091 and 32,557,303 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively   3
Total equity   $ 529,486